XML 47 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ (Deficit) Equity - Additional Information (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Aug. 12, 2025
USD ($)
Aug. 11, 2025
$ / shares
shares
Jun. 17, 2025
USD ($)
$ / shares
shares
Feb. 07, 2024
USD ($)
director
$ / shares
shares
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Sep. 30, 2025
USD ($)
shares
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock issuance costs | $         $ 142   $ 8,449      
Accumulated currency translation adjustments | $         400     $ 400   $ 500
Total stock-based compensation expense | $         $ 2,349 $ 2,964   $ 7,550 $ 11,075  
Stock options                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Stock option repricing program, minimum exercise price (in USD per share) | $ / shares     $ 10.14              
Stock option repricing program, minimum exercise price reduced (in USD per share) | $ / shares     $ 10.14              
Share-based payment award, options, eligible and outstanding, number | shares     1,700,000              
Total stock-based compensation expense | $     $ 700              
Private Placement                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares issued in transaction (in shares) | shares   1,000,000.0   10,500,000            
Common stock, par or stated value (in USD per share) | $ / shares   $ 0.0001                
Share price (in USD per share) | $ / shares   $ 2.24   $ 12.00            
Total gross proceeds | $ $ 10,000                  
Stock issuance costs | $ $ 100                  
Total gross proceeds | $       $ 127,800            
Private Placement | Two Directors                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Number of shares issued in transaction (in shares) | shares       23,000            
Share price (in USD per share) | $ / shares       $ 13.50            
Number of directors | director       2            
Private Placement | Pre-Funded Warrants                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Common stock issued upon exercise of warrants (in shares) | shares   3,500,000   75,000            
Share price (in USD per share) | $ / shares   $ 2.2399   $ 11.999            
Exercise price (in USD per share) | $ / shares   $ 0.0001   $ 0.001            
Beneficial ownership interest limitation (percent)   9.99%                
Warrants exercised (in shares) | shares         0     0